Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for acid-related diseases, today announced the screening of the first patient with ...

The latest announcement is out from Cinclus Pharma Holding AB ( ($SE:CINPHA) ). Cinclus Pharma Holding AB has commenced the screening of the first ...

Tegoprazan has comparable efficacy to proton pump inhibitors for H pylori eradication, with added benefit in clarithromycin-resistant strains.

Oxford University is leading a major international study looking to improve surgical treatment for people suffering from acid ...